1. Home
  2. ATAI vs AFRI Comparison

ATAI vs AFRI Comparison

Compare ATAI & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • AFRI
  • Stock Information
  • Founded
  • ATAI 2018
  • AFRI 1943
  • Country
  • ATAI Germany
  • AFRI Gibraltar
  • Employees
  • ATAI N/A
  • AFRI N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • AFRI Packaged Foods
  • Sector
  • ATAI Health Care
  • AFRI Consumer Staples
  • Exchange
  • ATAI Nasdaq
  • AFRI Nasdaq
  • Market Cap
  • ATAI 282.6M
  • AFRI 231.2M
  • IPO Year
  • ATAI 2021
  • AFRI N/A
  • Fundamental
  • Price
  • ATAI $1.41
  • AFRI $7.92
  • Analyst Decision
  • ATAI Strong Buy
  • AFRI
  • Analyst Count
  • ATAI 3
  • AFRI 0
  • Target Price
  • ATAI $10.50
  • AFRI N/A
  • AVG Volume (30 Days)
  • ATAI 1.4M
  • AFRI 24.0K
  • Earning Date
  • ATAI 05-19-2025
  • AFRI 05-13-2025
  • Dividend Yield
  • ATAI N/A
  • AFRI N/A
  • EPS Growth
  • ATAI N/A
  • AFRI N/A
  • EPS
  • ATAI N/A
  • AFRI N/A
  • Revenue
  • ATAI $308,000.00
  • AFRI $274,223,000.00
  • Revenue This Year
  • ATAI $65.58
  • AFRI N/A
  • Revenue Next Year
  • ATAI N/A
  • AFRI N/A
  • P/E Ratio
  • ATAI N/A
  • AFRI N/A
  • Revenue Growth
  • ATAI N/A
  • AFRI N/A
  • 52 Week Low
  • ATAI $1.03
  • AFRI $7.56
  • 52 Week High
  • ATAI $2.57
  • AFRI $12.00
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 44.57
  • AFRI 33.81
  • Support Level
  • ATAI $1.36
  • AFRI $7.56
  • Resistance Level
  • ATAI $1.54
  • AFRI $8.50
  • Average True Range (ATR)
  • ATAI 0.09
  • AFRI 0.30
  • MACD
  • ATAI -0.00
  • AFRI -0.05
  • Stochastic Oscillator
  • ATAI 0.00
  • AFRI 34.95

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About AFRI Forafric Global PLC

Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.

Share on Social Networks: